期刊文献+

北京地区伴2型糖尿病的缺血性卒中患者二级预防现况:一项门诊连续就诊脑卒中患者横断面调查 被引量:4

Secondary Prevention Situation of Ischemic Stroke Outpatients with DM in Beijing,China:A Cross-Sectional Study of Consecutive Outpatients in Neurological Clinics
下载PDF
导出
摘要 目的:分析北京地区伴糖尿病缺血性卒中(Ischemic Stroke,IS)和短暂性脑缺血发作(Transient ischemia attach,TIA)患者的二级预防状况。方法:本研究采用横断面调查(现况调查)方法,对北京11家二、三级医院神经内科门诊连续就诊IS或TIA患者进行问卷式调查,得到数据整合分析。结果:北京地区11家医院,2006年7月1~8月15日期间总计有1247例卒中患者的数据纳入分析中。伴2型糖尿病的患者351(351/1238,28.4%),其中接受降血糖药物治疗者273例(273/323,84.5%),未用药者50例(50/323,15.5%)。各类降糖药物使用情况依次为双胍类126(126/351,35.9%)、α-糖苷酶类97(97/351,27.6%)、磺脲类90(90/351,25.6%)、胰岛素63(63/351,17.9%)。口服抗血小板药物病例282例(282/348,81.0%)。获得空腹血糖数据病例数219例(62.4%),血糖控制良好(4.4~6.1mmol/L)、一般(≤7.0mmol/L)和不良(>7.0mmol/L)的比例数分别为27.9%、23.3%和48.9%。获得餐后血糖数据病例数152例(43.3%),其血糖控制良好(4.4~8.0mmol/L),一般(≤10.0mmol/L),不良(>10.0mmol/L)比例数分别为30.9%、30.9%和38.2%。获得血压数据345名(345/351,98.3%),血压达标(BP<130/80mmHg)43名(43/345,12.5%),未达标(BP≥130/80mmHg)302名(302/345,87.5%)。伴2型糖尿病患者中89名(89/351,25.4%)患者有LDL的记录,LDL达标(LDL≤2.6mmol/L)的患者39例(39/89,43.8%)。结论:伴糖尿病缺血性脑卒中患者血糖、血压和血脂情况患者记录比率低、控制达标率低,临床医生应当依照临床指南要求加强对这些伴有糖尿病的IS和TIA患者的教育和治疗,使其进行严格的血糖、血压和血脂的监控和管理。 Objective:Background and objective:The aim of this investigation was to evaluate the current status of secondary prevention in patients of Ischemic Stroke(IS) and Transient Ischemic Attack(TIA) with DM in 10 hospitals in Beijing,China.Methods:A cross-sectional(current status) survey was applied to study the current secondary prevention of stroke in the consecutively collected patients with IS or TIA in neurological clinics in the 10 Grade Ⅱ or Ⅲ hospitals in Beijing,China from June 1 to August 15 in 2006.Results:Data from total 1247 stroke patients of 11 hospitals in Beijing from June 1 to August 15 in 2006 were collected for analysis.There were 351(28.4%) patients accompanied with diabetic mellitus in all the 1238 IS or TIA patients.In 351 type 2 diabetic mellitus patients,273(273/323,84.5%) patients accept hypoglycemic agent therapy,50(50/323,15.5%) patients did not accept any medication.The use of drug in order was Biguanides 126(126/351,35.9%),123(123/336,36.6%),α-glucosidase 97(97/351,27.6%),sulph anylureas 90(90/351,25.6%) and Insuline 63(63/351,17.9%).There were 282(282/348,81.0%) patients taking antiplatelet drugs.There were219(62.4%)patients testing the fasting blood glucose and recording the data,among them the patients had good control of the blood glucose(4.4~6.1 mmol/L) was 27.9%,had common control(≤7.0 mmol/L)was 23.3% and bad control was 48.9%.There were 152(43.3%) patients testing the postprandial blood sugar and recording the data,among them the good,common and bad control of the blood glucose were 30.9%、30.9% and 38.2% each.The patients who had recorded the blood pressure was 345(345/351,98.3%),among them there were 43(43/345,12.5%)patients had good control(BP〈130/80mmHg)of the blood pressure and 302(302/345,87.5%)had bad control(BP≥130/80mmHg).Among the 351 type 2 diabetic mellitus patients,there were only 89 patients(89/351,25.4%)had recorded the LDL(low density lipoprotein),low d
出处 《脑与神经疾病杂志》 2008年第4期241-245,共5页 Journal of Brain and Nervous Diseases
基金 "十一五"国家科技支撑计划项目(2006BAI01A11) 北京市科学技术委员会重大项目(D0805004040231)
关键词 卒中 糖尿病 二级预防 stroke diabetes mellitus secondary prevention
  • 相关文献

参考文献10

  • 1Selvin E, Marinopoulos S, Berkenblit G, et al. Meta-analysis: glycated haemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med, 2004,141:421-431. 被引量:1
  • 2Petty GW, Brown RD Jr, Whisnant JP, et al. Survival and recurrence after first cerebral infarction: a population- based study in Rochester, Minnesota, 1975 through 1989. Neurology, 1998, 50: 208 -216. 被引量:1
  • 3Phyo K. Myint, MRCP; Shubhada Sinha, MRCP; et al. Glycated Hemoglobin and Risk of Stroke in People Without Known Diabetes in the European Prospective Investigation Into Cancer (EPIC)- Norfolk Prospective Population Study A Threshold Relationship? Stroke, 2007,38 : 271-275. 被引量:1
  • 4Thomas Almdal, DMSc; Henrik Scharling, MS; Jan Skov Jensen, DMSc; et al. The Independent Effect of Type 2 Diabetes Mellitus on Ischemic Heart Disease, Stroke, and Death. Arch Intern Med, 2004.164 : 1422-1426. 被引量:1
  • 5Ralph L. Sacco, MD, MS, FAHA, FAAN, Chair; Robert Adams, MD, FAHA, Vice Chair;Greg Albers, MD; Mark J. Alberts,MD, FAHA; Oscar Benavente, MD; Karen Furie, MD, MPH, FAHA; Larry B. Goldstein, MD, FAHA, FAAN;Philip Gorelick, MD, MPH, FAHA, FAAN; Jonathan Halperin, MD, FAHA; Robert Harbaugh, MD, FACS, FAHA; S. Claiborne Johnston, MD, PhD; Irene Katzan, MD, FAHA; Margaret Kelly-Hayes, RN, EdD, FAHA; Edgar J. Kenton, MD, FAHA, FAAN; Michael Marks, MD;Lee H. Schwamm, MD, FAHA; Thomas Tomsick, MD, FAHA. Guidelines for Prevention of Stroke in Patients with Ischemic Stroke or Transient Ischemic Attack A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke Co-Sponsored by the Council on Cardiovascular Radiology and Intervention The American Academy of Neurology affirms the value. Stroke, 2006, 37: 577- 617. 被引量:1
  • 6Karapanayiotides T, Piechowski-Jozwiak B, van Melle G, et al. Stroke patterns, etiology, and prognosis in patients with diabetes mellitus. Neurology, 2004 , 62 : 1558-1562. 被引量:1
  • 7Megherbi SE, Milan C, Minier D, et al. Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project. Stroke, 2003,34:688-694. 被引量:1
  • 8潘长玉,中国区合作调查组.中国糖尿病控制现状——指南与实践的差距 亚洲糖尿病治疗现状调查1998,2001及2003年中国区结果介绍[J].国外医学(内分泌学分册),2005,25(3):174-178. 被引量:396
  • 9Karin M. Nelson,MD,MSHS Gayle Reiber,et al. Diet and Exercise Among Audits With Type 2 diabetes. Diabetes Care, 2002,21(10): 1722-1728. 被引量:1
  • 10Sripal Bangalore, MD, MHAa, Sanobar Parkar, et aI. Messerli, MDa Beta Blockers to Determine the Risk of New-Onset Diabetes Mellitus. Am J Cardiol, 2007,100 (8) : 1254 -126. 被引量:1

二级参考文献2

共引文献395

同被引文献32

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部